Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT201601045623N64
IRCT201601045623N64
Completed
Phase 3

Clinical trial of the effect of selenium supplementation compared with the placebo on metabolic profiles in pregnant women at risk for intrauterine growth restriction

Vice chancellor for research, Kashan University of Medical Sciences0 sites60 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPregnancy.Sequelae of complication of pregnancy, childbirth and the puerperium

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Pregnancy.
Sponsor
Vice chancellor for research, Kashan University of Medical Sciences
Enrollment
60
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Vice chancellor for research, Kashan University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • •Pregnant women at risk for intrauterine growth restriction
  • •Aged 18 to 40 years

Exclusion Criteria

  • •Taking selenium supplements during past 3 months
  • •Hypo\- and hyperthyroidism
  • •Urinary tract infection
  • •Pre\-eclampsia
  • •Hypertension
  • •Diseases related to increased inflammation
  • •Kidney or liver diseases

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 3
Effect of supplementation in treatment of patients with gestational diabetesGestational diabetes.Diabetes mellitus in pregnancy, unspecifiedE28.2
IRCT201612045623N95Vice chancellor for research, Arak University of Medical Sciences40
Completed
Phase 3
Effect of supplementation in treatment of women with polycystic ovary syndrome of IVF candidatePolycystic ovarian syndrome.Polycystic ovarian syndromeE28.2
IRCT201704245623N113Vice chancellor for research, Shahid Beheshti University of Medical Sciences40
Completed
Phase 3
Effect of selenium supplementation in the treatment of women with polycystic ovary syndrome candidate for IVF.Polycystic ovarian syndrome.Polycystic ovarian syndromeE28.2
IRCT20170513033941N23Shahid Beheshti University of Medical Sciences40
Completed
Phase 3
Effect of selenium supplementation in treatment of gestational diabetes mellitus
IRCT20170513033941N35Iran University of Medical Sciences40
Completed
Phase 3
Effect of supplementation in treatment of Congestive Heart Failure
IRCT2017053033941N2Vice chancellor for research, Kashan University of Medical Sciences60